An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted online saying they started taking Wegovy (a prescription weight-loss drug) after gaining weight while recovering from a hip replacement. They lost about 12 kg (26 lbs) in the first three months, but then hit a plateau and haven’t lost any weight for five months despite eating only one meal a day and staying active. They asked if others had the same experience and for tips. Wegovy is the brand name for semaglutide at a higher dose than the diabetes version called Ozempic. Semaglutide is a lab-made version of a hormone your gut uses to tell your brain “you’re full” and to slow how fast the stomach empties. In people who take it, appetite often goes down and smaller meals feel satisfying, which can lead to weight loss when combined with diet and activity. What this report shows is a real-world experience, not a controlled study. Early weight loss on semaglutide is common, and many people see a rapid drop at first. Plateaus also happen — the body adjusts, and the initial rate of loss often slows or stops. This single-person post doesn’t measure long-term averages, rule out other causes, or test different doses or timings, so it can’t tell us how typical the plateau is or why it happened for this person. This matters because lots of people use Wegovy and expect steady, ongoing weight loss. If you start strong and then stall, it can be discouraging. Knowing plateaus are common helps set realistic expectations: the drug can produce meaningful weight loss for many, but it’s usually part of a longer-term plan that includes ongoing diet, activity, and medical follow-up. People recovering from surgery or with changed activity levels may also have shifting calorie needs, which can affect progress. Important caveats: a single social media post can’t identify medical causes like injury-related muscle loss, medication interactions, changes in metabolism after weight loss, or underestimating calorie intake. Semaglutide has side effects (nausea, stomach issues, possible risk signals seen in studies) and is prescription-only. It’s not safe to stop or change doses without talking to your doctor. If weight loss stalls, doctors can evaluate other factors (thyroid, medications, muscle vs fat changes) and discuss behavioral strategies, dose adjustments, or referral to a specialist. Bottom line: Early drops on Wegovy aren’t unusual and plateaus happen — if progress stalls, check in with your prescriber rather than guessing at causes or making big changes on your own.
Source: r/Semaglutide